Celltrion gets approval of Omlyclo in Canada

Celltrion gets approval of Omlyclo in Canada

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

Celltrion applies for approval of Xolair biosimilar in Canada

Celltrion applies for approval of Xolair biosimilar in Canada

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...

Hanwha Systems to compete with LIG Nex1 for Korean version of Iron Dome NH, KB Securities, Kookmin Bank, Kim & Chang lead capital markets in H1 From G-Dragon to Ibuki: Dongmyo emerges as global fashion hotspot Hyundai helps Korean economy most with $265 bn contribution South Korea issues €1.4 billion in largest-ever euro bond sale
banner